Wells Score Calculator
Calculate the Wells Score for Deep Vein Thrombosis (DVT) to estimate clinical pre-test probability. Select all criteria that apply to your patient.
Quick Answer
The Wells Score for DVT assigns points for clinical features: +1 for each positive criterion (active cancer, paralysis, bedridden >3 days, tenderness, leg swelling, calf asymmetry >3cm, pitting edema, collateral veins, prior DVT), and -2 if an alternative diagnosis is equally likely. Score interpretation: 0 or less = low probability (~5%), 1-2 = moderate (~17%), 3+ = high (~75%).
Clinical Criteria
Select all that apply to the patient
Results
Clinical Recommendation
D-dimer testing is appropriate. If negative, DVT can be safely excluded without imaging in most patients.
Score Interpretation
About This Tool
The Wells Score for Deep Vein Thrombosis (DVT) is one of the most widely used clinical prediction rules in emergency medicine and internal medicine. Originally published by Dr. Philip Wells and colleagues in 1997, and subsequently validated and refined in numerous studies, this scoring system helps clinicians estimate the pre-test probability of DVT before ordering diagnostic tests. The Wells Score has fundamentally changed the approach to DVT diagnosis by enabling safe, cost-effective diagnostic pathways that reduce unnecessary imaging.
How the Wells Score Works
The Wells Score assigns points based on ten clinical criteria derived from the patient's history and physical examination. Nine criteria each add one point for positive findings: active cancer (receiving treatment or palliation within 6 months), paralysis or recent plaster immobilization of the lower extremities, recently bedridden for more than 3 days or major surgery within 12 weeks, localized tenderness along the distribution of the deep venous system, entire leg swelling, calf swelling more than 3 cm compared to the asymptomatic leg (measured 10 cm below the tibial tuberosity), pitting edema confined to the symptomatic leg, collateral non-varicose superficial veins, and previously documented DVT. The tenth criterion subtracts two points when an alternative diagnosis is at least as likely as DVT. This negative criterion is crucial because it accounts for the many conditions that can mimic DVT, including cellulitis, Baker's cyst, muscle strain, lymphedema, and superficial thrombophlebitis.
Interpreting the Score
The original Wells model stratifies patients into three risk categories. A score of 0 or less indicates low probability, with approximately 5% of these patients having DVT on subsequent testing. A score of 1 to 2 indicates moderate probability, with approximately 17% prevalence. A score of 3 or more indicates high probability, with DVT prevalence approaching 75%. An alternative two-level model (used in some clinical settings) classifies scores of 2 or more as "DVT likely" and scores below 2 as "DVT unlikely." Both versions have been extensively validated in diverse clinical populations.
Clinical Decision Pathway
The Wells Score is most powerful when integrated into a structured diagnostic algorithm. For low-probability patients, a negative high-sensitivity D-dimer test effectively rules out DVT, with a negative predictive value exceeding 99%. For moderate-probability patients, D-dimer testing is appropriate as a first step; a positive D-dimer should prompt compression ultrasonography. For high-probability patients, imaging should be performed directly, as D-dimer testing alone is insufficient to safely exclude DVT in this group. This risk-stratified approach has been shown to reduce unnecessary ultrasound examinations by 30-40% while maintaining diagnostic safety.
Limitations and Special Populations
The Wells Score has important limitations. It has been primarily validated in ambulatory outpatient populations and may be less accurate in hospitalized patients, post-surgical patients, or pregnant women. D-dimer levels are physiologically elevated in pregnancy, elderly patients, patients with cancer, and those recovering from surgery, which reduces the specificity of D-dimer testing in these groups. The scoring system also relies on subjective clinical assessment, particularly the "alternative diagnosis" criterion, which introduces variability between clinicians. Despite these limitations, the Wells Score remains the most widely used and best-validated clinical prediction rule for DVT assessment worldwide.
Evidence and Validation
The Wells Score has been validated in more than 20 prospective studies across multiple countries, involving tens of thousands of patients. A landmark 2003 study by Wells et al. published in the New England Journal of Medicine demonstrated that combining the Wells Score with D-dimer testing could safely exclude DVT in outpatients without the need for ultrasound imaging. Subsequent meta-analyses have confirmed its diagnostic accuracy across diverse healthcare settings, solidifying its position as a cornerstone of venous thromboembolism diagnosis. Major clinical guidelines from the American College of Chest Physicians (ACCP), the National Institute for Health and Care Excellence (NICE), and the American Society of Hematology (ASH) all recommend using the Wells Score as part of the DVT diagnostic workup.